TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.51
-0.01 (-0.13%)
Apr 1, 2026, 1:57 PM CST
Market Cap602.52M -17.9%
Revenue (ttm)n/a
Net Income-25.36M
EPS-0.32
Shares Out80.12M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume55,104
Average Volume135,670
Open7.57
Previous Close7.52
Day's Range7.25 - 7.57
52-Week Range6.99 - 10.60
Beta-1.54
RSI45.56
Earnings DateApr 7, 2026

About TaiwanJ Pharmaceuticals

TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. Th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 13
Stock Exchange Taipei Exchange
Ticker Symbol 6549
Full Company Profile

Financial Performance

Financial Statements